Interactions between wild-type and mutant Ras genes in lung and skin carcinogenesis.

Abstract:

:Ras oncogenes (Hras, Kras and Nras) are important drivers of carcinogenesis. However, tumors with Ras mutations often show loss of the corresponding wild-type (WT) allele, suggesting that proto-oncogenic forms of Ras can function as a suppressor of carcinogenesis. In vitro studies also suggest that WT Ras proteins can suppress the tumorigenic properties of alternate mutant Ras family members, but in vivo evidence for these heterologous interactions is lacking. We have investigated the genetic interactions between different combinations of mutant and WT Ras alleles in vivo using carcinogen-induced lung and skin carcinogenesis in mice with targeted deletion of different Ras family members. The major suppressor effect of WT Kras is observed only in mutant Kras-driven lung carcinogenesis, where loss of one Kras allele led to increased tumor number and size. Deletion of one Hras allele dramatically reduced the number of skin papillomas with Hras mutations, consistent with Hras as the major target of mutation in these tumors. However, skin carcinoma numbers were very similar, suggesting that WT Hras functions as a suppressor of progression from papillomas to invasive squamous carcinomas. In the skin, the Kras proto-oncogene functions cooperatively with mutant Hras to promote papilloma development, although the effect is relatively small. In contrast, the Hras proto-oncogene attenuated the activity of mutant Kras in lung carcinogenesis. Interestingly, loss of Nras increased the number of mutant Kras-induced lung tumors, but decreased the number of mutant Hras-induced skin papillomas. These results show that the strongest suppressor effects of WT Ras are only seen in the context of mutation of the cognate Ras protein, and only relatively weak effects are detected on tumor development induced by mutations in alternative family members. The data also underscore the complex and context-dependent nature of interactions between proto-oncogenic and oncogenic forms of different Ras family members during tumor development.

journal_name

Oncogene

journal_title

Oncogene

authors

To MD,Rosario RD,Westcott PM,Banta KL,Balmain A

doi

10.1038/onc.2012.404

subject

Has Abstract

pub_date

2013-08-22 00:00:00

pages

4028-33

issue

34

eissn

0950-9232

issn

1476-5594

pii

onc2012404

journal_volume

32

pub_type

杂志文章

相关文献

ONCOGENE文献大全
  • TPX2/Aurora kinase A signaling as a potential therapeutic target in genomically unstable cancer cells.

    abstract::Genomic instability is a hallmark feature of cancer cells, and can be caused by defective DNA repair, for instance due to inactivation of BRCA2. Paradoxically, loss of Brca2 in mice results in embryonic lethality, whereas cancer cells can tolerate BRCA2 loss. This holds true for multiple DNA repair genes, and suggests...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0470-2

    authors: van Gijn SE,Wierenga E,van den Tempel N,Kok YP,Heijink AM,Spierings DCJ,Foijer F,van Vugt MATM,Fehrmann RSN

    更新日期:2019-02-01 00:00:00

  • Soluble CD44 inhibits melanoma tumor growth by blocking cell surface CD44 binding to hyaluronic acid.

    abstract::Proteolytic cleavage of the extracellular domain of CD44 from the surface of cells has been observed recently in different cell types. In cell culture supernatants of human melanoma cell lines a 70 kDa soluble CD44 protein (solCD44) was detected at concentrations of 250-300 ng/ml. Protease inhibitor studies revealed t...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204435

    authors: Ahrens T,Sleeman JP,Schempp CM,Howells N,Hofmann M,Ponta H,Herrlich P,Simon JC

    更新日期:2001-06-07 00:00:00

  • p12(CDK2-AP1) mediates DNA damage responses induced by cisplatin.

    abstract::We examined the biological role of p12(CDK2-AP1) in cisplatin-mediated responses by using murine ES p12(CDK2-AP1) knockout clones generated by a targeted disruption of murine p12(CDK2-AP1). Homozygous knockout clones showed an increased cellular proliferation along with an increase in S and a decrease in G2/M phase po...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1208222

    authors: Kim Y,McBride J,Zhang R,Zhou X,Wong DT

    更新日期:2005-01-13 00:00:00

  • Retroviral heterogeneity in mouse lymphomas.

    abstract::Provirus modifications which can occur in tumors may lead to tumor antigenic variants. To investigate this possibility we compared the restriction fragment length patterns of mouse mammary tumor virus (MMTV), murine leukemia virus and xenotropic and mink cell-focus inducing (MCF)-related sequences, using Southern blot...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Colombo MP,Ferrari G,Parmiani G,Wettstein PJ

    更新日期:1988-04-01 00:00:00

  • The miR-106b-25 cluster targets Smad7, activates TGF-β signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer.

    abstract::The role of TGF-β signaling in tumorigenesis is paradoxical: it can be tumor suppressive or tumor promotional, depending on context. The metastatic regulator, Six1, was recently shown to mediate this switch, providing a novel means to explain this elusive 'TGF-β paradox'. Herein, we identify a mechanism by which Six1 ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.11

    authors: Smith AL,Iwanaga R,Drasin DJ,Micalizzi DS,Vartuli RL,Tan AC,Ford HL

    更新日期:2012-12-13 00:00:00

  • ARHI is a Ras-related small G-protein with a novel N-terminal extension that inhibits growth of ovarian and breast cancers.

    abstract::Our group recently identified Ras homolog member I (ARHI), a novel maternally imprinted tumor suppressor gene that encodes a 26 kDa GTP-binding protein with high homology to Ras and Rap. Unlike other Ras family members, ARHI exhibits several unusual structural and functional properties. ARHI contains a unique 34 amino...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206380

    authors: Luo RZ,Fang X,Marquez R,Liu SY,Mills GB,Liao WS,Yu Y,Bast RC

    更新日期:2003-05-15 00:00:00

  • Identifying targets for the restoration and reactivation of BRM.

    abstract::Brahma (BRM) is a novel anticancer gene, which is frequently inactivated in a variety of tumor types. Unlike many anticancer genes, BRM is not mutated, but rather epigenetically silenced. In addition, histone deacetylase complex (HDAC) inhibitors are known to reverse BRM silencing, but they also inactivate it via acet...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.613

    authors: Kahali B,Gramling SJ,Marquez SB,Thompson K,Lu L,Reisman D

    更新日期:2014-01-30 00:00:00

  • GSK3β phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21.

    abstract::KLF6, a ubiquitously expressed Krüppel-like transcription factor, is frequently inactivated in human cancer and has significant roles in cellular proliferation, apoptosis, differentiation and development. A key mechanism of KLF6-mediated growth suppression is through p53-independent transactivation of p21. Several can...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2012.457

    authors: Lang UE,Kocabayoglu P,Cheng GZ,Ghiassi-Nejad Z,Muñoz U,Vetter D,Eckstein DA,Hannivoort RA,Walsh MJ,Friedman SL

    更新日期:2013-09-19 00:00:00

  • Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma.

    abstract::Germline BAP1 mutations predispose to several cancers, in particular malignant mesothelioma. Mesothelioma is an aggressive malignancy generally associated with professional exposure to asbestos. However, to date, we found that none of the mesothelioma patients carrying germline BAP1 mutations were professionally expos...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.243

    authors: Napolitano A,Pellegrini L,Dey A,Larson D,Tanji M,Flores EG,Kendrick B,Lapid D,Powers A,Kanodia S,Pastorino S,Pass HI,Dixit V,Yang H,Carbone M

    更新日期:2016-04-14 00:00:00

  • Functional homology between N-myc and c-myc in murine plasmacytomagenesis: plasmacytoma development in N-myc transgenic mice.

    abstract::Mouse plasmacytomas induced by pristane oil alone, or in combination with Abelson murine leukemia virus (A-MuLV), regularly carry one of three alternative chromosomal translocations that juxtapose c-myc to immunoglobulin heavy- or light-chain loci. E mu-c-myc transgenic mice develop translocation-free plasmacytomas af...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Wang Y,Sugiyama H,Axelson H,Panda CK,Babonits M,Ma A,Steinberg JM,Alt FW,Klein G,Wiener F

    更新日期:1992-06-01 00:00:00

  • Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

    abstract::The p53 gene has been implicated as a tumor suppressor gene with mutations found in common human cancers. We examined 51 early stage, primary, resected non-small cell lung cancer specimens using an RNAase protection assay and cDNA sequencing. Mutations changing the p53 coding sequence were found in 23/51 (45%) tumor s...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Chiba I,Takahashi T,Nau MM,D'Amico D,Curiel DT,Mitsudomi T,Buchhagen DL,Carbone D,Piantadosi S,Koga H

    更新日期:1990-10-01 00:00:00

  • HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1.

    abstract::In this study, we show that the ETS transcription factor ER81 directly binds to and activates the promoter of the matrix metalloproteinase gene, MMP-1. Further, the oncoprotein HER2/Neu synergizes with ER81 to stimulate MMP-1 transcription. The activation of ER81 by HER2/Neu is mediated by MAP kinases, which phosphory...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1204820

    authors: Bosc DG,Goueli BS,Janknecht R

    更新日期:2001-09-27 00:00:00

  • CtBP promotes metastasis of breast cancer through repressing cholesterol and activating TGF-β signaling.

    abstract::Metastasis is the process through which the primary cancer cells spread beyond the primary tumor and disseminate to other organs. Most cancer patients die of metastatic disease. EMT is proposed to be the initial event associated with cancer metastasis and how it occurred is still a mystery. CtBP is known as a co-repre...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-018-0570-z

    authors: Zhao Z,Hao D,Wang L,Li J,Meng Y,Li P,Wang Y,Zhang C,Zhou H,Gardner K,Di LJ

    更新日期:2019-03-01 00:00:00

  • Silencing of imprinted CDKN1C gene expression is associated with loss of CpG and histone H3 lysine 9 methylation at DMR-LIT1 in esophageal cancer.

    abstract::The putative tumor suppressor CDKN1C is an imprinted gene at 11p15.5, a well-known imprinted region often deleted in tumors. The absence of somatic mutations and the frequent diminished expression in tumors would suggest that CDKN1C expression is regulated epigenetically. It has been, however, controversial whether th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1207576

    authors: Soejima H,Nakagawachi T,Zhao W,Higashimoto K,Urano T,Matsukura S,Kitajima Y,Takeuchi M,Nakayama M,Oshimura M,Miyazaki K,Joh K,Mukai T

    更新日期:2004-05-27 00:00:00

  • Laser capture microdissection-based in vivo genomic profiling of wound keratinocytes identifies similarities and differences to squamous cell carcinoma.

    abstract::Keratinocytes undergo a dramatic phenotypic conversion during reepithelialization of skin wounds to become hyperproliferative, migratory, and invasive. This transient healing response phenotypically resembles malignant transformation of keratinocytes during squamous cell carcinoma progression. Here we present the firs...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1206614

    authors: Pedersen TX,Leethanakul C,Patel V,Mitola D,Lund LR,Danø K,Johnsen M,Gutkind JS,Bugge TH

    更新日期:2003-06-19 00:00:00

  • Wn mutation of c-kit receptor affects its post-translational processing and extracellular expression.

    abstract::The W locus of mice encodes the c-kit receptor tyrosine kinase. Recently, we characterized a novel mutant allele, Wn, and demonstrated that the c-kit protein synthesized in Wn/Wn cultured mast cells (CMC) was reduced in size and not expressed on their surface (Tsujimura et al., 1993). In this study, we further examine...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Koshimizu U,Tsujimura T,Isozaki K,Nomura S,Furitsu T,Kanakura Y,Kitamura Y,Nishimune Y

    更新日期:1994-01-01 00:00:00

  • Regulation of the bi-directional cross-talk between ovarian cancer cells and adipocytes by SPARC.

    abstract::Ovarian cancer (OvCa) exhibits a specific predilection for metastasis to the omentum. Our earlier studies highlighted the tumour-suppressor effect of secreted protein acidic and rich in cysteine (SPARC) in OvCa through multi-faceted roles inhibiting cancer cell interactions within the peritoneal milieu. The goal of th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0728-3

    authors: John B,Naczki C,Patel C,Ghoneum A,Qasem S,Salih Z,Said N

    更新日期:2019-05-01 00:00:00

  • Association with Cdc2 and inhibition of Cdc2/Cyclin B1 kinase activity by the p53-regulated protein Gadd45.

    abstract::Recently Gadd45, a p53-regulated stress protein, has been implicated in the activation of a G2/M checkpoint after damage by UV radiation and alkylating agents. While inhibitory phosphorylation of Cdc2 and suppression of cyclin B1 levels are known to be involved in G2 delays after genotoxic stress, Gadd45 has now been ...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202667

    authors: Zhan Q,Antinore MJ,Wang XW,Carrier F,Smith ML,Harris CC,Fornace AJ Jr

    更新日期:1999-05-06 00:00:00

  • AP2α controls the dynamic balance between miR-126&126* and miR-221&222 during melanoma progression.

    abstract::Accumulating evidences have shown the association between aberrantly expressed microRNAs (miRs) and cancer, where these small regulatory RNAs appear to dictate the cell fate by regulating all the main biological processes. We demonstrated the responsibility of the circuitry connecting the oncomiR-221&222 with the tumo...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2015.357

    authors: Felli N,Errico MC,Pedini F,Petrini M,Puglisi R,Bellenghi M,Boe A,Felicetti F,Mattia G,De Feo A,Bottero L,Tripodo C,Carè A

    更新日期:2016-06-09 00:00:00

  • Crosstalk between NRF2 and HIPK2 shapes cytoprotective responses.

    abstract::Homeodomain interacting protein kinase-2 (HIPK2) is a member of the HIPK family of stress-responsive kinases that modulates cell growth, apoptosis, proliferation and development. HIPK2 has several well-characterised tumour suppressor roles, but recent studies suggest it can also contribute to tumour progression, altho...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2017.221

    authors: Torrente L,Sanchez C,Moreno R,Chowdhry S,Cabello P,Isono K,Koseki H,Honda T,Hayes JD,Dinkova-Kostova AT,de la Vega L

    更新日期:2017-11-02 00:00:00

  • Function for p300 and not CBP in the apoptotic response to DNA damage.

    abstract::The cellular response to ionizing radiation (IR) includes the induction of apoptosis. The p300/CBP proteins possess histone acetyltransferase activity and function as transcriptional coactivators of p53. We have prepared cells deficient in p300 or CBP to define the roles of these proteins in the cellular response to D...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1202930

    authors: Yuan ZM,Huang Y,Ishiko T,Nakada S,Utsugisawa T,Shioya H,Utsugisawa Y,Shi Y,Weichselbaum R,Kufe D

    更新日期:1999-10-07 00:00:00

  • The Drosophila homolog of the human tumor suppressor gene BHD interacts with the JAK-STAT and Dpp signaling pathways in regulating male germline stem cell maintenance.

    abstract::Birt-Hogg-Dubé syndrome (BHD) is a rare, inherited genodermatosis characterized by hair follicle hamartomas, kidney tumors and spontaneous pneumothorax. The BHD locus was mapped to chromosome 17p11.2 by linkage analysis, and germline mutations in a novel gene (BHD) were identified in a panel of BHD families. Using RNA...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/sj.onc.1209593

    authors: Singh SR,Zhen W,Zheng Z,Wang H,Oh SW,Liu W,Zbar B,Schmidt LS,Hou SX

    更新日期:2006-09-28 00:00:00

  • Retrospective analysis of ras gene activation in myeloid leukemic cells.

    abstract::Ras genes are activated by point mutations at critical sites of their coding regions. Activated N-ras genes with transforming ability have been detected in patients with myelodysplastic syndromes (MDS), acute myelogenous leukemia (AML) and in human myeloid cell lines. We used polymerase chain reaction (PCR), different...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Lübbert M,Jonas D,Miller CW,Herrmann F,Mertelsmann R,McCormick F,Koeffler HP

    更新日期:1990-04-01 00:00:00

  • Parkin and mitophagy in cancer.

    abstract::Mitophagy, the selective engulfment and clearance of mitochondria, is essential for the homeostasis of a healthy network of functioning mitochondria and prevents excessive production of cytotoxic reactive oxygen species from damaged mitochondria. The mitochondrially targeted PTEN-induced kinase-1 (PINK1) and the E3 ub...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/onc.2016.302

    authors: Bernardini JP,Lazarou M,Dewson G

    更新日期:2017-03-01 00:00:00

  • Met-induced membrane blebbing leads to amoeboid cell motility and invasion.

    abstract::Met tyrosine kinase has been implicated in tumorigenesis and metastasis; its overexpression and deregulation is often observed in cancer. Although Met's functions in cell motility has been studied extensively, its involvement in bleb-based, amoeboid motility is yet to be determined. The aim of this work is to study th...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2013.138

    authors: Laser-Azogui A,Diamant-Levi T,Israeli S,Roytman Y,Tsarfaty I

    更新日期:2014-04-03 00:00:00

  • Identifying LRRC16B as an oncofetal gene with transforming enhancing capability using a combined bioinformatics and experimental approach.

    abstract::Oncofetal genes are expressed in embryos or fetuses, are downregulated or undetectable in adult tissues, and then re-expressed in tumors. Known oncofetal genes, such as AFP, GCB, FGF18, IMP-1 and SOX1, often have important clinical applications or pivotal biological functions. To find new oncofetal-like genes, we used...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/onc.2010.451

    authors: Hsu CC,Chiang CW,Cheng HC,Chang WT,Chou CY,Tsai HW,Lee CT,Wu ZH,Lee TY,Chao A,Chow NH,Ho CL

    更新日期:2011-02-10 00:00:00

  • DNA damage signalling guards against activated oncogenes and tumour progression.

    abstract::DNA damage response (DDR), the guardian of genomic integrity, emerges as an oncogene-inducible biological barrier against progression of cancer beyond its early stages. Recent evidence from both cell culture and animal models as well as analyses of clinical specimens show that activation of numerous oncogenes and loss...

    journal_title:Oncogene

    pub_type: 杂志文章,评审

    doi:10.1038/sj.onc.1210881

    authors: Bartek J,Bartkova J,Lukas J

    更新日期:2007-12-10 00:00:00

  • Transgenic mice carrying a murine amylase 2.2/SV40 T antigen fusion gene develop pancreatic acinar cell and stomach carcinomas.

    abstract::The mouse pancreatic amylase Amy-2.2 gene was fused to the structural gene for SV40 T antigen, and 51 independent transgenic founder mice carrying the fusion gene were generated. The majority of the founders and 100% of their offspring in the derived transgenic lines developed pancreatic acinar cell carcinomas and sto...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Ceci JD,Kovatch RM,Swing DA,Jones JM,Snow CM,Rosenberg MP,Jenkins NA,Copeland NG,Meisler MH

    更新日期:1991-02-01 00:00:00

  • p53/BNIP3-dependent mitophagy limits glycolytic shift in radioresistant cancer.

    abstract::The role of p53 in genotoxic therapy-induced metabolic shift in cancers is not yet known. In this study, we investigated the role of p53 in the glycolytic shift in head and neck squamous cell carcinoma cell lines following irradiation. Isogenic p53-null radioresistant cancer cells established through cumulative irradi...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:10.1038/s41388-019-0697-6

    authors: Chang HW,Kim MR,Lee HJ,Lee HM,Kim GC,Lee YS,Nam HY,Lee M,Jang HJ,Lee KE,Lee JC,Byun Y,Kim SW,Kim SY

    更新日期:2019-05-01 00:00:00

  • Restriction and complexity of Mcf2 proto-oncogene expression.

    abstract::MCF2/DBL is an X-linked proto-oncogene encoding a protein with a yet undetermined function. It can be activated in vitro by loss of 5' sequences in NIH3T3 bioassays; in vivo, deletion of the gene has been found in some hemophilia B patients. PCR analysis of its expression in mouse tissues shows a restriction to the go...

    journal_title:Oncogene

    pub_type: 杂志文章

    doi:

    authors: Galland F,Pirisi V,de Lapeyriere O,Birnbaum D

    更新日期:1991-05-01 00:00:00